Efficacy of Bevacizumab and Gemcitabine in Combination with Cisplatin in the Treatment of Esophageal Cancer and the Effect on the Incidence of Adverse Reactions

Figure 2

Comparison of Cyfra21-1 levels in the two groups before and after treatment (). Note: The abscissa indicates before and after treatment, and the ordinate indicates Cyfra21-1 level, pg/L. The Cyfra21-1 levels before and after treatment in the control group were () pg/L and () pg/L, respectively. The Cyfra21-1 levels before and after treatment in the study group were () pg/L and () pg/L, respectively. indicates a significant difference in Cyfra21-1 levels before and after treatment in the control group (, ). indicates a significant difference in Cyfra21-1 levels before and after treatment in the study group (, ). indicates a significant difference in Cyfra21-1 levels between the study group and the control group after treatment (, ).